From Deep-Tech Research to Global Impact: How Meticuly is Complementing Healthcare with Patient-Specific Implants

On 10th June 2026, Assoc. Prof. Dr Boonrat Lohwongwatana, Chief Executive Officer and co-founder of Meticuly, took the stage at the NANOTEC Knowledge Sharing forum. Speaking on the theme "Deep-Tech Startup Success: Scaling Innovative Businesses for Sustainable Growth", Dr Boonrat shared invaluable insights into Meticuly's journey from a university research project to a globally recognised medical technology pioneer.

As the first and only Thai deep-tech startup to successfully integrate Artificial Intelligence (AI) into the design of world-class titanium bone replacements, Meticuly is shifting the paradigm of complex surgeries. By bridging advanced digital engineering with clinical execution, the company has transformed how complex Oral and maxillofacial reconstructions and Orthognathic jaw alignments are performed.

The Shift from One-Size Fits all to Patient-Specific Implants via Virtual Surgical Planning and 3D Printing

Traditional off-the-shelf medical implants often require surgeons to manually adapt mass-produced plates to a patient's unique anatomy during surgery. Meticuly eliminates this challenge by leveraging advanced 3D printing technology to manufacture a patient-specific implant tailored precisely to an individual's CT or MRI scans. Meticuly eliminates this intraoperative guesswork entirely through advanced Virtual surgical planning.

For instance, following a life-saving craniectomy (the surgical removal of part of the skull to relieve brain pressure), restoring the bone defect historically relied on manual configuration. Surgeons would have to intraoperatively bend and shape a standard titanium mesh cranioplasty plate to try and replicate the natural contours of the patient’s skull. Using patient CT or MRI scans, specialised software maps out the precise anatomical landscape before anyone enters the operating room. This digital framework allows for the creation of a highly contoured Cranioplasty implant that fits seamlessly into place, reducing complications and drastically lowering time spent under anesthesia.

By combining AI-driven generative design with premium titanium 3D printing, Meticuly produces highly customisable, bio-compatible implants that:

• Significantly reduce operating theatre time.

• Improve post-operative anatomical alignment and structural integrity.

• Accelerate patient recovery and enhance long-term quality of life.

Surviving the 'Valley of Death' in Deep-Tech

Scaling a medical technology startup involves navigating unique complexities. During his session, Dr Boonrat discussed how Meticuly successfully crossed the notorious "Valley of Death"—the challenging period between initial research and sustainable revenue generation.

He highlighted several critical milestones that secured Meticuly’s global standing:

• Overcoming Regulatory Hurdles: Securing stringent international certifications, including US FDA clearances and CE MDR compliance.

• Global Trust and Scaling: Partnering with over 250 leading hospitals worldwide to deploy 3D printing healthcare solutions at scale.

• Intellectual Property Protection: Establishing robust legal strategies to protect proprietary AI design algorithms and titanium fabrication techniques against copycat firms.

The Future of Personalised Medicine

Meticuly’s success serves as a blueprint for Southeast Asian deep-tech enterprises aiming for the global market. By bridging the gap between advanced digital engineering and clinical application, the company continues to redefine what is possible in personalized orthopaedic care.